Lysosomal storage disorders

Lysosomal storage disorders are a large group of inherited conditions. They affect lysosomes, which are small structures inside cells that break down and recycle fats, sugars, proteins, and other materials.

Each disorder interferes with a particular part of this recycling process. Often, the body is missing an enzyme—a protein that speeds up a chemical reaction—or the enzyme does not work properly. Material then builds up inside cells. Over time, this can affect how tissues and organs work.

Examples include Gaucher disease, Fabry disease, Pompe disease, metachromatic leukodystrophy, Niemann-Pick disease, and the mucopolysaccharidoses. Although grouped together, these conditions can differ greatly in their symptoms, age of onset, treatment, and outlook.

Some begin before birth or during early childhood. Others cause few problems until adolescence or adulthood. Early identification matters because treatment can sometimes slow or prevent damage, especially when started before major symptoms develop.

Symptoms depend on the exact disorder, the organs affected, and how much working enzyme the body produces. People in the same family can sometimes have different symptoms or levels of severity.

Possible signs in babies and children include:

• Feeding problems, slow growth, or poor weight gain
• Delayed development or loss of previously learned skills
• Low muscle tone, muscle weakness, or difficulty walking
• Frequent chest infections or noisy breathing
• An enlarged liver or spleen, causing a swollen abdomen
• Changes in facial features, joints, bones, hearing, or vision

Some disorders mainly affect the brain and nerves. They may cause changes in movement, balance, speech, learning, behaviour, or memory. Seizures can occur in certain types.

Others mainly affect organs outside the brain. Symptoms may include bone pain, easy bruising, low blood cell counts, reduced exercise tolerance, heart problems, kidney disease, or burning pain in the hands and feet.

Adult-onset disease may be less obvious. Unexplained heart thickening, kidney problems, nerve pain, muscle weakness, or early strokes can sometimes lead to testing. These symptoms also have many more common causes, so having one does not mean you have a lysosomal storage disorder.

Lysosomal storage disorders are caused by changes in genes involved in cell recycling. Genes are instructions used by the body to make proteins. A harmful gene change may reduce or stop the activity of an enzyme or another lysosomal protein.

Most of these conditions follow an autosomal recessive inheritance pattern. This means a child usually inherits one altered copy of the gene from each parent. The parents are often healthy carriers and may not know they carry the change.

Some, including Fabry disease and Hunter syndrome, are linked to the X chromosome. These may affect people differently depending on their chromosomes, and some carriers can develop important symptoms.

The main risk factor is a biological family history of the condition or the gene change. However, a disorder can be diagnosed without any known family history. It may have gone unrecognised in relatives, or both parents may be healthy carriers.

Diet, exercise, parenting, and everyday activities do not cause these conditions.

Diagnosis may begin after symptoms appear, through testing of an affected relative, or through newborn screening. Newborn screening checks babies for selected conditions shortly after birth, but the disorders included differ by location. A screening result is not the same as a diagnosis.

Testing may include blood or urine measurements of substances that build up when lysosomes do not work properly. Enzyme activity testing measures how well a particular enzyme works. A low result may strongly suggest a specific disorder, but further testing is often needed.

Genetic testing looks for disease-causing changes in the relevant gene. It can confirm many lysosomal storage disorders and clarify how the condition may be inherited. Some results are uncertain and need interpretation by a genetics or metabolic specialist.

Other tests assess which organs are affected. These may include:

• Blood counts and liver or kidney tests
• Heart tests, such as an electrocardiogram or echocardiogram
• Hearing, vision, breathing, or movement assessments
• MRI or other imaging of the brain, bones, liver, or spleen

The exact testing plan is specific to the suspected disorder. Dried blood spot tests are useful for screening but sometimes need confirmation using a different blood sample or cell type.

Treatment is different for each disorder. Care is often coordinated by a specialist metabolic or genetics centre, with support from heart, kidney, lung, nerve, bone, eye, hearing, and rehabilitation teams as needed.

Enzyme replacement therapy provides a manufactured form of a missing enzyme, usually through regular infusions. It is available for some disorders, including certain forms of Gaucher, Fabry, Pompe, and mucopolysaccharidosis. It can improve or stabilise some organ problems but may not reach the brain well.

Substrate reduction therapy lowers the amount of material the body produces for the lysosome to break down. Chaperone therapy helps certain altered enzymes fold correctly and reach the lysosome. These treatments work only for particular disorders or gene changes.

A blood-forming stem cell transplant may be considered for selected conditions, especially when treatment can begin early. It replaces the cells that produce certain enzymes. Transplant has serious risks and does not repair all existing damage.

Gene therapy is available for a small number of selected disorders and is being studied for others. It aims to give cells a working genetic instruction. Eligibility, likely benefit, and long-term uncertainty are specific to each therapy.

Supportive care remains important even when disease-specific treatment is available. It can include physical or occupational therapy, hearing aids, breathing support, pain management, nutrition support, educational help, and treatment for heart, kidney, bone, or seizure problems.

Material buildup can gradually damage affected organs. Possible complications include loss of movement or communication skills, chronic lung disease, swallowing problems, heart muscle or valve disease, kidney failure, fractures, vision or hearing loss, and reduced independence.

An enlarged spleen can contribute to low blood counts and easy bleeding. Bone disease can cause pain, joint stiffness, spine changes, or fractures. Some disorders increase the risks associated with anaesthesia because of airway, heart, lung, or neck problems.

Not everyone develops these complications. Their likelihood is shaped by the specific disorder, gene changes, age at onset, and response to treatment.

Inherited lysosomal storage disorders cannot usually be prevented through lifestyle changes.

Genetic counselling can explain inheritance and the chance of the condition affecting relatives or future pregnancies. When a family’s gene change is known, options may include carrier testing, testing during pregnancy, or testing embryos created through in vitro fertilisation. These are personal choices rather than requirements.

Newborn screening does not prevent the genetic condition. For disorders with effective early treatment, however, screening may help reduce or delay some complications.

The course over months and years is specific to the disorder. Some forms remain mild and allow a mostly independent adult life. Others progress during childhood or adulthood and can cause major disability or shorten life.

Treatment may reduce symptoms, protect organs, or slow further damage. It may not reverse injury that has already occurred, particularly in the brain and nerves. Regular monitoring can identify changes before they become obvious and show whether treatment is helping.

Follow-up may include blood tests, scans, hearing and vision checks, heart tests, breathing tests, and assessments of movement or development. Treatment plans often change as a child grows or as an adult’s health and daily needs change.

Regular infusions, appointments, fatigue, pain, mobility limits, or learning needs can affect school, work, travel, and family life. Rehabilitation, school adjustments, workplace support, mobility equipment, and mental health care can help people maintain activities and independence.

Relatives may also be offered testing. Finding another affected family member early can matter because symptoms may not yet be noticeable.

Arrange routine follow-up with the specialist team at the recommended intervals, even if symptoms seem stable. Contact the team sooner for a gradual decline in walking, school or work performance, hearing, vision, breathing, swallowing, or ability to manage daily activities.

Seek prompt medical advice for new weakness, repeated falls, worsening pain, reduced eating or drinking, persistent vomiting, increasing abdominal swelling, or a noticeable drop in exercise tolerance. A new seizure or sudden change in alertness also needs urgent assessment.

Call emergency services for:

• Severe breathing difficulty, blue or grey lips, or inability to speak
• A seizure lasting five minutes or longer, or repeated seizures without recovery
• Sudden facial drooping, arm weakness, speech difficulty, or loss of balance
• Severe chest pain, collapse, or unresponsiveness
• Choking with an inability to breathe or cough effectively

If you have a confirmed disorder, carry emergency information about the diagnosis, medicines, airway concerns, and specialist contact details. This can be especially important before surgery or anaesthesia.

Are lysosomal storage disorders inherited?

Yes. They are caused by gene changes passed through families, although there may be no known family history. The inheritance pattern differs between disorders. Genetic testing and counselling can clarify what a result means for biological relatives.

Can adults develop a lysosomal storage disorder?

The gene change is present from birth, but symptoms may not appear until adulthood. Some adult-onset forms mainly affect the heart, kidneys, nerves, muscles, or bones and may progress slowly.

Can lysosomal storage disorders be cured?

Most do not currently have a cure. Disease-specific treatments may slow progression or control certain organ problems. Gene therapy or stem cell transplant may offer lasting correction for selected disorders, but these options are not suitable for every person or every type.

Can newborn screening find these conditions?

Newborn screening can identify some lysosomal storage disorders before symptoms begin, but the conditions tested for differ by location. An out-of-range screening result requires confirmatory biochemical and genetic testing.

What is the life expectancy with a lysosomal storage disorder?

There is no single estimate for the whole group. Some people have mild disease and live into older adulthood. Severe forms can cause life-threatening complications in childhood or adulthood. The exact diagnosis, organs affected, and access and response to treatment shape the outlook.

Is a lysosomal storage disorder contagious?

No. These conditions are caused by inherited gene changes. They cannot be caught from or passed to another person through contact.